Soliton Inc
NASDAQ:SOLY
Soliton Inc
Additional Paid In Capital
Soliton Inc
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Soliton Inc
NASDAQ:SOLY
|
Additional Paid In Capital
$101.5m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Additional Paid In Capital
$19.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
25%
|
|
Boston Scientific Corp
NYSE:BSX
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Stryker Corp
NYSE:SYK
|
Additional Paid In Capital
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Additional Paid In Capital
$8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
See Also
What is Soliton Inc's Additional Paid In Capital?
Additional Paid In Capital
101.5m
USD
Based on the financial report for Dec 31, 2020, Soliton Inc's Additional Paid In Capital amounts to 101.5m USD.
What is Soliton Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
69%
Over the last year, the Additional Paid In Capital growth was 53%. The average annual Additional Paid In Capital growth rates for Soliton Inc have been 69% over the past three years .